Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMV

IMV (IMV) Stock Price, News & Analysis

IMV logo

About IMV Stock (NASDAQ:IMV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.49
$0.91
52-Week Range
N/A
Volume
44,800 shs
Average Volume
233,607 shs
Market Capitalization
$9.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

IMV Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Is This The Next Toyota FJ Cruiser?
See More Headlines

IMV Stock Analysis - Frequently Asked Questions

IMV Inc. (NASDAQ:IMV) announced its quarterly earnings data on Thursday, November, 11th. The company reported ($1.30) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($1.30). The business had revenue of $0.04 million for the quarter. IMV had a negative trailing twelve-month return on equity of 12,695.41% and a negative net margin of 11,547.42%.

IMV's stock reverse split before market open on Tuesday, December 13th 2022.The 1-10 reverse split was announced on Tuesday, December 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMV investors own include Pfizer (PFE), Nokia (NOK), NIO (NIO), Inovio Pharmaceuticals (INO), Dynavax Technologies (DVAX), VBI Vaccines (VBIV) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/11/2021
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMV
CIK
1734768
Fax
N/A
Employees
97
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.99 million
Net Margins
-11,547.42%
Pretax Margin
-11,547.42%
Return on Equity
-12,695.41%
Return on Assets
-104.84%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.93
Quick Ratio
2.93

Sales & Book Value

Annual Sales
$330 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.69) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,712,000
Free Float
11,673,000
Market Cap
$9.63 million
Optionable
Optionable
Beta
0.95
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:IMV) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners